研究実績

Multicenter phase II trial of adjuvant S-1 plus Docetaxel for 6 months in patients with pathological stage III gastric cancer (OGSG1002)

Kazuyoshi Yamamoto ,Kazumasa Fujitani ,Shigeyuki Tamura ,Junya Fujita ,Jin Matsuyama ,Yutaka Kimura ,Hiroshi Imamura ,Yoichi Makari ,Yukinori Kurokawa,Toshimasa Tsujinaka ,Hiroshi Furukawa ,Taro Sato on behalf of the Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG). ESMO2015, Vienna, Austria,25-29 Sep 2015

前の記事 次の記事 一覧ページへ戻る